Concourse Financial Group Securities, Inc. Compass Therapeutics, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CMPX
# of Institutions
82Shares Held
92.4MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$69.5 Million0.97% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$34.6 Million0.04% of portfolio
-
Blackstone Inc New York, NY10MShares$31.2 Million0.09% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$20.6 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA5.64MShares$17.5 Million1.62% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $315M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...